(Q35671712)

9 August 2017

1 reference

title

MUC1 immunobiology: from discovery to clinical applications (English)

1 reference

9 August 2017

Anda M Vlad

1

1 reference

9 August 2017

Jessica C Kettel

2

1 reference

9 August 2017

Nehad M Alajez

3

1 reference

9 August 2017

Casey A Carlos

4

1 reference

9 August 2017

Olivera J Finn

5

1 reference

9 August 2017

1 January 2004

1 reference

9 August 2017

Advances in Immunology

1 reference

9 August 2017

82

1 reference

9 August 2017

249-293

1 reference

MUC1-specific immune responses in human MUC1 transgenic mice immunized with various human MUC1 vaccines

9 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Cancer-associated MUC1 mucin inhibits human T-cell proliferation, which is reversible by IL-2

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Significance of MUC1 and MUC2 mucin expression in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

MUC-1 expression as a predictor of the curative endoscopic treatment of submucosally invasive colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Oxidative/reductive conjugation of mannan to antigen selects for T1 or T2 immune responses.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

MUC1 peptide epitopes associated with five different H-2 class I molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Cyclophosphamide enhances the CTL precursor frequency in mice immunized with MUC1-mannan fusion protein (M-FP)

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Crystal structure of a non-canonical high affinity peptide complexed with MHC class I: a novel use of alternative anchors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Mucin gene expression in Barrett's oesophagus: an in situ hybridisation and immunohistochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Altered expression of MUC2, MUC4, and MUC5 mucin genes in pancreas tissues and cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Biochemistry and pathological importance of mucin-associated antigens in gastrointestinal neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Comparative evaluation of the prognostic value of MUC1, MUC2, sialyl-Lewis(a) and sialyl-Lewis(x) antigens in colorectal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Tumour-induced suppression of immune response and its correction

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Chimpanzee dendritic cells derived in vitro from blood monocytes and pulsed with antigen elicit specific immune responses in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Preferential expression of novel MUC1 tumor antigen isoforms in human epithelial tumors and their tumor-potentiating function

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Role of TGF-beta in immune-evasion of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Cloning of a human UDP-N-acetyl-alpha-D-Galactosamine:polypeptide N-acetylgalactosaminyltransferase that complements other GalNAc-transferases in complete O-glycosylation of the MUC1 tandem repeat

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Expression of core 2 beta-1,6-N-acetylglucosaminyltransferase in a human pancreatic cancer cell line results in altered expression of MUC1 tumor-associated epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Mucin gene transcripts in benign and borderline mucinous tumours of the ovary: an in situ hybridization study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

The product of the human MUC1 gene when secreted by mouse cells transfected with the full-length cDNA lacks the cytoplasmic tail

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Spatial and temporal analyses of integrin and Muc-1 expression in porcine uterine epithelium and trophectoderm in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Developmental mucin gene expression in the gastroduodenal tract and accessory digestive glands. I. Stomach. A relationship to gastric carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Mucin gene expression in intestinal epithelial cells in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

O-linked glycosylation in the mammary gland: changes that occur during malignancy.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Expression of MUC1, Thomsen-Friedenreich antigen, Tn, sialosyl-Tn, and alpha2,6-linked sialic acid in hepatocellular carcinomas and preneoplastic hepatocellular lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Cell signaling through membrane mucins

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

MUC1 gene polymorphism and gastric cancer--an epidemiological study.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

The epithelial mucin, MUC1, is expressed on resting T lymphocytes and can function as a negative regulator of T cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Targeted antigen delivery to antigen-presenting cells including dendritic cells by engineered Fas-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Non-glycosylated tandem repeats of MUC1 facilitate attachment of breast tumor cells to normal human lung tissue and immobilized extracellular matrix proteins (ECM) in vitro: potential role in metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

From normal respiratory mucosa to epidermoid carcinoma: expression of human mucin genes.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Form and pattern of MUC1 expression on T cells activated in vivo or in vitro suggests a function in T-cell migration.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Humoral immune response induced by the protein core of MUC1 mucin in pregnant and healthy women

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Detection of circulating mammary mucin (Muc1) and MUC1 immune complexes (Muc1-CIC) in healthy women

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Histological studies of gene-ablated mice support important functional roles for natural killer cells in the uterus during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

The relative activities of the C2GnT1 and ST3Gal-I glycosyltransferases determine O-glycan structure and expression of a tumor-associated epitope on MUC1.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

The MUC family: an obituary.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Human lymphoid cells express epithelial membrane antigen. Implications for diagnosis of human neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Mucin functions and expression in mammalian reproductive tract tissues.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

MUC1/episialin: a critical barrier in the female reproductive tract

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Design and expression of a synthetic mucin gene fragment in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Identification and topology of variant sequences within individual repeat domains of the human epithelial tumor mucin MUC1

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Constitutive and inducible expression of the epithelial antigen MUC1 (CD227) in human T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Dendritic cells in cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Human immunodeficiency virus (HIV) antigens: structure and serology of multivalent human mucin MUC1-HIV V3 chimeric proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Structure of a tumor associated antigen containing a tandemly repeated immunodominant epitope

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Epithelial mucin genes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Cloning of partial cDNA encoding differentiation and tumor-associated mucin glycoproteins expressed by human mammary epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Immunotherapy of cancer with dendritic-cell-based vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Reversal of tolerance to human MUC1 antigen in MUC1 transgenic mice immunized with fusions of dendritic and carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Tyrosine kinase c-Src constitutes a bridge between cystic fibrosis transmembrane regulator channel failure and MUC1 overexpression in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

A phase I trial of a synthetic mucin peptide vaccine. Induction of specific immune reactivity in patients with adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Intramuscular immunisation with MUC1 cDNA can protect C57 mice challenged with MUC1-expressing syngeneic mouse tumour cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Adoptive T Cell Therapy of Tumors: Mechanisms Operative in the Recognition and Elimination of Tumor Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

MUC17, a novel membrane-tethered mucin.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Circulating anti-MUC1 IgG antibodies as a favorable prognostic factor for pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Analysis of MUC4 mucin expression in lung carcinoma cells and its immunogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

MUC1: the polymorphic appearance of a human mucin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Dynamic epigenetic regulation of initial O-glycosylation by UDP-N-Acetylgalactosamine:Peptide N-acetylgalactosaminyltransferases. site-specific glycosylation of MUC1 repeat peptide influences the substrate qualities at adjacent or distant Ser/Thr po

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Evidence for glycosylation-dependent activities of polypeptide N-acetylgalactosaminyltransferases rGalNAc-T2 and -T4 on mucin glycopeptides.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Vaccination against tumor cells expressing breast cancer epithelial tumor antigen.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Identification of three non-VNTR MUC1-derived HLA-A*0201-restricted T-cell epitopes that induce protective anti-tumor immunity in HLA-A2/K(b)-transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Molecular cloning and hormone-dependent expression of rabbit Muc1 in the cervix and uterus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Mucin (Muc-1) expression is differentially regulated in uterine luminal and glandular epithelia of the baboon (Papio anubis)

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

The mechanism of unresponsiveness to circulating tumor antigen MUC1 is a block in intracellular sorting and processing by dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Detection of a circulating antibody against a peptide epitope on a mucin core protein, MUC1, in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Enhancement of reactivity of anti-MUC1 core protein antibody and killing activity of anti-MUC1 cytotoxic T cells by deglycosylation of target tissues or cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Immunoreactive MUC1 expression at the deepest invasive portion correlates with prognosis of colorectal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Human MUC1 mucin: a potent glandular morphogen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Cancer statistics, 2003.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

A survivor of breast cancer with immunity to MUC-1 mucin, and lactational mastitis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Long-term tumor growth suppression in mice immunized with naked DNA of the human tumor antigen mucin (MUC1).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Formation of MUC1 metabolic complex is conserved in tumor-derived and normal epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Age at last full-term pregnancy and risk of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Antibody and T cell responses of patients with adenocarcinoma immunized with mannan-MUC1 fusion protein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Mannan mucin-1 peptide immunization: influence of cyclophosphamide and the route of injection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Antigen loss variants of a murine renal cell carcinoma: implications for tumor vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Comparison of the effect of different immunological adjuvants on the antibody and T-cell response to immunization with MUC1-KLH and GD3-KLH conjugate cancer vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Effect of immunological adjuvant combinations on the antibody and T-cell response to vaccination with MUC1-KLH and GD3-KLH conjugates.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Enrichment of differentiated CD45RBdim,CD27- memory T cells in the peripheral blood, synovial fluid, and synovial tissue of patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Induction of antitumor immunity by vaccination of dendritic cells transfected with MUC1 RNA

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

The kinetics of in vivo priming of CD4 and CD8 T cells by dendritic/tumor fusion cells in MUC1-transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

MUC1 mucin and trefoil factor 1 protein expression in renal cell carcinoma: correlation with prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Muc1, a mucin-like protein that is regulated by Mss10, is critical for pseudohyphal differentiation in yeast

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Expression of human mucin genes in normal kidney and renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

MUC1 expression is correlated with nuclear grade and tumor progression in pT1 renal clear cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Expression of MUC1 and MUC2 mucins and relationship with cell proliferative activity in human colorectal neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Cloning of the amino-terminal and 5'-flanking region of the human MUC5AC mucin gene and transcriptional up-regulation by bacterial exoproducts

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

The Human DF3/MUC1 carcinoma-associated antigen signals nuclear localization of the catenin p120(ctn)

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

The epidermal growth factor receptor regulates interaction of the human DF3/MUC1 carcinoma antigen with c-Src and beta-catenin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

A single nucleotide polymorphism in an exon dictates allele dependent differential splicing of episialin mRNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Muc1 mucins on the cell surface are adhesion sites for Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Approaches to augmenting the immunogenicity of melanoma gangliosides: from whole melanoma cells to ganglioside-KLH conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Carbohydrate vaccines that induce antibodies against cancer. 2. Previous experience and future plans

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Phase 1 trial of immunological adjuvant QS-21 with a GM2 ganglioside-keyhole limpet haemocyanin conjugate vaccine in patients with malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Mucins as differentiation markers in bronchial epithelium. Squamous cell carcinoma and adenocarcinoma display similar expression patterns

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

In vivo antigen loading and activation of dendritic cells via a liposomal peptide vaccine mediates protective antiviral and anti-tumour immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

The mucin profile of noninvasive and invasive mucinous cystic neoplasms of the pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Development of semisynthetic triterpenoid saponin derivatives with immune stimulating activity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Adenovirus-Mediated MUC1 gene transduction into human blood-derived dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Overexpression of MUC1 reconfigures the binding properties of tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Factors effecting the measurement of tumor-associated MUC1 mucins in serum

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Blockade of the granzyme B/perforin pathway through overexpression of the serine protease inhibitor PI-9/SPI-6 constitutes a mechanism for immune escape by tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Construction and characterization of a chimeric receptor containing the cytoplasmic domain of MUC1 mucin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

MUC1 and endometrial receptivity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Dendritic cell/macrophage precursors capture exogenous antigen for MHC class I presentation by dendritic cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Alternative splicing generates a family of putative secreted and membrane-associated MUC4 mucins

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Crossregulation Between Th1 and Th2 Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Influence of organ site and tumor cell type on MUC1-specific tumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Mice with spontaneous pancreatic cancer naturally develop MUC-1-specific CTLs that eradicate tumors when adoptively transferred

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Localization of O-glycosylation sites on glycopeptide fragments from lactation-associated MUC1. All putative sites within the tandem repeat are glycosylation targets in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Reevaluation of the cellular immune response in breast cancer patients vaccinated with MUC1

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Serum KL-6 level as a monitoring marker in a patient with pulmonary alveolar proteinosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Detection of circulating anti-MUC1 mucin core protein antibodies in patients with colorectal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Membrane-bound (MUC1) and secretory (MUC2, MUC3, and MUC4) mucin gene expression in human lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Cytotoxic T lymphocytes derived from bone marrow mononuclear cells of multiple myeloma patients recognize an underglycosylated form of MUC1 mucin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Novel MUC1 splice variants are expressed in cervical carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Comparison of MUC-1 mucin expression in epithelial and non-epithelial cancer cell lines and demonstration of a new short variant form (MUC-1/Z).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Isolation and characterization of MUC15, a novel cell membrane-associated mucin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Cystic fibrosis mice lacking Muc1 have reduced amounts of intestinal mucus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Identification of MUC1 proteolytic cleavage sites in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

MUC1 and MUC-X, epithelial mucins of breast and milk

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Induction of cellular immunity in chimpanzees to human tumor-associated antigen mucin by vaccination with MUC-1 cDNA-transfected Epstein-Barr virus-immortalized autologous B cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Mucin gene (MUC1) transfected dendritic cells as vaccine: results of a phase I/II clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

The epithelial mucin MUC1 contains at least two discrete signals specifying membrane localization in cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Structural and functional aspects of three major glycoproteins of the human milk fat globule membrane

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Isolation of MUC1-primed B lymphocytes from tumour-draining lymph nodes by immunomagnetic beads

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Mucins MUC1, MUC2, MUC5AC and MUC6 expression in the evaluation of differentiation and clinico-biological behaviour of gastric carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Summary report on the ISOBM TD-4 Workshop: analysis of 56 monoclonal antibodies against the MUC1 mucin. San Diego, Calif., November 17-23, 1996.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Phosphorylation of the cytoplasmic domain of the MUC1 mucin correlates with changes in cell-cell adhesion

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Anti-MUC1 class I restricted CTLs in metastatic breast cancer patients immunized with a synthetic MUC1 peptide.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Protein kinase C delta regulates function of the DF3/MUC1 carcinoma antigen in beta-catenin signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Antibodies reactive with the protein core of MUC1 mucin are present in ovarian cancer patients and healthy women.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Degradation of cell proteins and the generation of MHC class I-presented peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

A new era for cancer immunotherapy based on the genes that encode cancer antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Regulated expression of MUC1 epithelial antigen in erythropoiesis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Expression of mucin 1 (MUC1) in esophageal squamous-cell carcinoma: its relationship with prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Recombinant vaccinia virus encoding human MUC1 and IL2 as immunotherapy in patients with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Transgenic MUC1 interacts with epidermal growth factor receptor and correlates with mitogen-activated protein kinase activation in the mouse mammary gland

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Isolation and characterization of mucin-like glycoprotein in human milk fat globule membrane

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Squamous differentiation downregulates Muc1 mucin in hamster tracheal surface epithelial cell

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Inhibition of CD40 expression and CD40-mediated dendritic cell function by tumor-derived IL-10

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Isolation and sequencing of a cDNA coding for the human DF3 breast carcinoma-associated antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

MUC1 gene polymorphism in the gastric carcinogenesis pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Patterns of episialin/MUC1 expression in endometrial carcinomas and prognostic relevance

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Melanomas with concordant loss of multiple melanocytic differentiation proteins: immune escape that may be overcome by targeting unique or undefined antigens.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Detection of a secreted MUC1/SEC protein by MUC1 isoform specific monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Cellular and humoral immune responses to MUC1 mucin and tandem-repeat peptides in ovarian cancer patients and controls

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Recombinant human tumor antigen MUC1 expressed in insect cells: structure and immunogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Three different vaccines based on the 140-amino acid MUC1 peptide with seven tandemly repeated tumor-specific epitopes elicit distinct immune effector mechanisms in wild-type versus MUC1-transgenic mice with different potential for tumor rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Delayed mammary tumor progression in Muc-1 null mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Expression and steroid hormonal control of Muc-1 in the mouse uterus.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Circulating autoantibodies against purified colonic mucin in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

MUC1 expression in intramucosal colorectal neoplasms. Possible involvement in histogenesis and progression

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Tumor necrosis factor-alpha converting enzyme/ADAM 17 mediates MUC1 shedding

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Induction of humoral and cellular responses in cynomolgus monkeys immunised with mannan-human MUC1 conjugates.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

The immune response of mice and cynomolgus monkeys to macaque mucin 1-mannan

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Complex carbohydrates are not removed during processing of glycoproteins by dendritic cells: processing of tumor antigen MUC1 glycopeptides for presentation to major histocompatibility complex class II-restricted T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Humoral immune response to polymorphic epithelial mucin (MUC-1) in patients with benign and malignant breast tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Substrate specificities of three members of the human UDP-N-acetyl-alpha-D-galactosamine:Polypeptide N-acetylgalactosaminyltransferase family, GalNAc-T1, -T2, and -T3

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/MUC1.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

The MUC3 gene encodes a transmembrane mucin and is alternatively spliced

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Muc13, a novel human cell surface mucin expressed by epithelial and hemopoietic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Human epithelial tumor antigen cDNA sequences. Differential splicing may generate multiple protein forms.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Interaction of the DF3/MUC1 breast carcinoma-associated antigen and beta-catenin in cell adhesion

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Expression of MUC1 and MUC2 mucin core proteins and their messenger RNA in gall bladder carcinoma: an immunohistochemical and in situ hybridization study.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Cancer-associated immunodeficiency and dendritic cell abnormalities mediated by the prostaglandin EP2 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Ovarian cancer antigen CA125 is encoded by the MUC16 mucin gene

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Human milk mucin inhibits rotavirus replication and prevents experimental gastroenteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Cancer vaccines: progress reveals new complexities

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

A MUC1 mucin secreted from a colon carcinoma cell line inhibits target cell lysis by natural killer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Current methods for loading dendritic cells with tumor antigen for the induction of antitumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Tyrosine phosphorylation of the MUC1 breast cancer membrane proteins. Cytokine receptor-like molecules.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

Therapeutic antitumor response after immunization with an admixture of recombinant vaccinia viruses expressing a modified MUC1 gene and the murine T-cell costimulatory molecule B7.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2982006-6

7 January 2021

10.1016/S0065-2776(04)82006-6

Identifiers

DOI

1 reference

release_3qzea7drwbhbpih3rxrjrzo334

9 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3qzea7drwbhbpih3rxrjrzo334

24 November 2022

mapped directly with Wikidata item

1 reference